Jinhua P. Zhang

#18 Daoshan Road
Fuzhou, 350001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 117 publications

Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care.

Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care.

Journal: Expert review of hematology

Published: June 20, 2026

Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database.

Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database.

Journal: Acta clinica Belgica

Published: April 20, 2026

Comparison of Bleeding Risks and All-Cause Death Between Warfarin and Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Multicenter Retrospective Cohort Study

Comparison of Bleeding Risks and All-Cause Death Between Warfarin and Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Multicenter Retrospective Cohort Study

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: February 25, 2026

Dipyridamole-associated pulmonary edema: discovery of a new potential adverse reaction signal based on the FAERS database.

Dipyridamole-associated pulmonary edema: discovery of a new potential adverse reaction signal based on the FAERS database.

Journal: Expert opinion on drug safety

Published: January 21, 2026

Association of GnRH agonists with depression and suicide/self-injury: a FAERS pharmacovigilance study.

Association of GnRH agonists with depression and suicide/self-injury: a FAERS pharmacovigilance study.

Journal: Endocrine connections

Published: November 27, 2025

Outcomes in patients with atrial fibrillation with and without heart failure on oral anticoagulants: a multicenter retrospective cohort study.

Outcomes in patients with atrial fibrillation with and without heart failure on oral anticoagulants: a multicenter retrospective cohort study.

Journal: Thrombosis journal

Published: October 13, 2025

Mining safety signals of PD-1/PD-L1 inhibitor-related adrenal insufficiency: a study based on the FAERS database.

Mining safety signals of PD-1/PD-L1 inhibitor-related adrenal insufficiency: a study based on the FAERS database.

Journal: Journal of endocrinological investigation

Published: October 10, 2025

Pharmacokinetic prediction and dosage adjustment of enoxaparin administration in pregnant women with renal insufficiency: A FAERS-PBPK modeling study.

Pharmacokinetic prediction and dosage adjustment of enoxaparin administration in pregnant women with renal insufficiency: A FAERS-PBPK modeling study.

Journal: Journal of pharmaceutical sciences

Published: August 05, 2025

Venous thromboembolism events associated with tofacitinib in rheumatoid arthritis patients: a real-world study from FAERS database.

Venous thromboembolism events associated with tofacitinib in rheumatoid arthritis patients: a real-world study from FAERS database.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: July 30, 2025

Argatroban-Associated Adverse Events: An Analysis Based on FDA Adverse Event Reporting System (FAERS).

Argatroban-Associated Adverse Events: An Analysis Based on FDA Adverse Event Reporting System (FAERS).

Journal: Cardiovascular toxicology

Published: June 19, 2025

Causal effects of childhood obesity on venous thromboembolism in adulthood: A bidirectional Mendelian randomization study.

Causal effects of childhood obesity on venous thromboembolism in adulthood: A bidirectional Mendelian randomization study.

Journal: Medicine

Published: June 09, 2025

A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system.

A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system.

Journal: Scientific reports

Published: May 28, 2025

Showing 1-12 of 117

Last Updated: 09/26/2026